← Alle Unternehmen
Über das Unternehmen
ABCDx provides powerful new tools for transforming the triage, diagnosis and treatment decision process at the point of care for patients presenting with potential brain injury from stroke and trauma to complications. ABCDx is pioneering the ability to decode the chemical messages of the brain so that brain injury can be detected earlier often before hospitalization and from a single blood drop. Currently, ABCDx is developing biomarker panels for three products: TBICheck™ for traumatic brain injuries, STROKECheck™ for differentiating between ischemic and haemorrhagic stroke and LVOCheck™ for triage of stroke patients with large vessel occlusions.